iShares MSCI United Kingdom (FTSE) vs Herbalife Nutrition Ltd — how do they compare? iShares MSCI United Kingdom (FTSE) trades at $46.52 (market cap $3.62B), while Herbalife Nutrition Ltd trades at $13.03 (market cap $1.34B). The key difference: iShares MSCI United Kingdom (FTSE) is far larger — about 2.7× Herbalife Nutrition Ltd's market cap, and iShares MSCI United Kingdom (FTSE) is trading nearer its 52-week high, Herbalife Nutrition Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI United Kingdom (FTSE) for 46 Days and Herbalife Nutrition Ltd for 43 Days on average.
| EWU | HLF | |
|---|---|---|
Market Cap | $3.62B | $1.34B |
Volume | 923,896 | 1,589,457 |
Sector | Broad Market / Factor | Consumer Staples |
52-Week High | $49.39 | $19.96 |
52-Week Low | $41.34 | $7.75 |
Typical Hold Time | 46 Days | 43 Days |
Enterprise Value | — | $3.18B |
Signals from Pluang's Aura AI — not financial advice
EWU trades at $46.23, up 0.65% on the day, but faces a bearish technical outlook with 16 sell signals versus 3 buy signals. The stock is testing key support at $46 amid rising UK gilt yields and inflation concerns. Recent UK housing policy announcements have boosted related sectors, but broader European economic pressures and ECB rate hikes create headwinds for the UK-focused ETF.
The outlook remains cautious given technical weakness and macroeconomic pressures from rising interest rates and energy prices. Investment opportunity exists if housing stimulus gains traction, but risks include prolonged inflation and further ECB tightening that could pressure UK equities.
HLF trades at $12.82, up 1.34% today, with a bullish technical signal from moving averages and oscillators. The company reported mixed quarterly earnings, beating in Q1 2026 but missing in Q4 2025 and Q2 2026. Revenue has been stable around $5.0B annually, with a net income margin of 4.53% in 2025. Recent news includes a $250 million share repurchase program and a planned CEO transition effective October 31, 2026.
The stock appears undervalued with a P/E of 8.22 and P/S of 0.26, supported by a 53.84% analyst buy rating and a $19.00 consensus price target. Key risks include high debt levels, with total liabilities at $3.53B, and inconsistent earnings performance. Positive cash flow trends in 2026 projections and margin expansion plans offer potential upside, but investor caution is warranted due to ongoing leadership changes and competitive pressures.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
EWU is a country-specific ETF that tracks the performance of the United Kingdom equity market. It provides exposure to large and mid-sized UK companies, with significant weightings in financials, energy, and healthcare, including Shell, AstraZeneca, and HSBC.
Read more on EWU →Herbalife Nutrition Ltd is an international nutrition company.
Read more on HLF →